Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 399

1.

Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.

Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, Lefaucheur C.

Kidney Int. 2017 Sep;92(3):729-742. doi: 10.1016/j.kint.2017.03.033. Epub 2017 May 26.

PMID:
28554738
2.

Clinical and pathological analyses of transplant glomerulopathy cases.

Shimizu T, Ishida H, Toki D, Nozaki T, Omoto K, Tanabe K, Honda K, Koike J.

Nephrology (Carlton). 2014 Jun;19 Suppl 3:21-6. doi: 10.1111/nep.12243.

PMID:
24842817
3.

Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.

Bailly E, Anglicheau D, Blancho G, Gatault P, Vuiblet V, Chatelet V, Morelon E, Malvezzi P, Parissiadis A, Tourret J, Guidicelli G, Sayegh J, Mousson C, Grimbert P, Top I, Le Quintrec M, Purgus R, Westeel PF, Proust B, Chabot V, Lebranchu Y, Dehaut F, Büchler M.

Transplantation. 2018 Apr;102(4):688-698. doi: 10.1097/TP.0000000000002002.

PMID:
29135832
4.

T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.

Lefaucheur C, Gosset C, Rabant M, Viglietti D, Verine J, Aubert O, Louis K, Glotz D, Legendre C, Duong Van Huyen JP, Loupy A.

Am J Transplant. 2018 Feb;18(2):377-390. doi: 10.1111/ajt.14565. Epub 2017 Nov 21.

5.

Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies.

Herman J, Lerut E, Van Damme-Lombaerts R, Emonds MP, Van Damme B.

Transplantation. 2005 May 27;79(10):1435-40.

PMID:
15912116
6.

Influence of preformed donor-specific antibodies and C4d on early liver allograft function.

Perera MT, Silva MA, Murphy N, Briggs D, Mirza DF, Neil DA.

Scand J Gastroenterol. 2013 Dec;48(12):1444-51. doi: 10.3109/00365521.2013.845795. Epub 2013 Oct 16.

PMID:
24131305
7.

Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.

Haas M, Mirocha J, Reinsmoen NL, Vo AA, Choi J, Kahwaji JM, Peng A, Villicana R, Jordan SC.

Kidney Int. 2017 Mar;91(3):729-737. doi: 10.1016/j.kint.2016.10.040. Epub 2017 Jan 16.

PMID:
28104301
8.

C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.

Banasik M, Boratyńska M, Nowakowska B, Haloń A, Kościelska-Kasprzak K, Drulis-Fajdasz D, Patrzałek D, Weyde W, Klinger M.

Transplant Proc. 2007 Nov;39(9):2718-20.

PMID:
18021967
9.

Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining.

Akalin E, Dinavahi R, Dikman S, de Boccardo G, Friedlander R, Schroppel B, Sehgal V, Bromberg JS, Heeger P, Murphy B.

Clin J Am Soc Nephrol. 2007 Nov;2(6):1261-7. Epub 2007 Oct 17.

10.

The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.

Roberts JA, Barrios R, Cagle PT, Ge Y, Takei H, Haque AK, Burns KM, Land GA, Dilioglou S, Bernard DW.

Arch Pathol Lab Med. 2014 Aug;138(8):1053-8. doi: 10.5858/arpa.2013-0539-OA. Epub 2013 Oct 28.

PMID:
24164556
11.

Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.

Cardarelli F, Pascual M, Tolkoff-Rubin N, Delmonico FL, Wong W, Schoenfeld DA, Zhang H, Cosimi AB, Saidman SL.

Transpl Int. 2005 May;18(5):532-40.

12.

Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies.

García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV.

Transplantation. 2017 Jun;101(6):1410-1415. doi: 10.1097/TP.0000000000001216.

PMID:
27163535
13.

Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.

Shimizu T, Toma H, Hayakawa N, Shibahara R, Ishiyama R, Hayashida A, Fujimori D, Tsunoyama K, Ikezawa E, Kitajima S, Iida S, Ishida H, Tanabe K, Honda K, Koike J.

Nephrology (Carlton). 2016 Jul;21 Suppl 1:26-30. doi: 10.1111/nep.12766.

PMID:
26972969
14.

Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation.

Okabe Y, Noguchi H, Miyamoto K, Kaku K, Tsuchimoto A, Masutani K, Nakamura M.

Transplant Proc. 2018 Dec;50(10):3460-3466. doi: 10.1016/j.transproceed.2018.07.033. Epub 2018 Aug 9.

PMID:
30577221
15.

Rejection of the Renal Allograft in the Absence of Demonstrable Antibody and Complement.

Zhao X, Huang G, Randhawa S, Zeng G, Lunz J, Randhawa P.

Transplantation. 2017 Feb;101(2):395-401. doi: 10.1097/TP.0000000000001118.

PMID:
26901079
16.

Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries.

Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, Williams WW, Cosimi AA, Schneeberger EE, Colvin RB.

J Am Soc Nephrol. 2001 Mar;12(3):574-82.

17.

Complement-binding anti-HLA antibodies and kidney-allograft survival.

Loupy A, Lefaucheur C, Vernerey D, Prugger C, Duong van Huyen JP, Mooney N, Suberbielle C, Frémeaux-Bacchi V, Méjean A, Desgrandchamps F, Anglicheau D, Nochy D, Charron D, Empana JP, Delahousse M, Legendre C, Glotz D, Hill GS, Zeevi A, Jouven X.

N Engl J Med. 2013 Sep 26;369(13):1215-26. doi: 10.1056/NEJMoa1302506.

18.

Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.

Lee H, Han E, Choi AR, Ban TH, Chung BH, Yang CW, Choi YJ, Oh EJ.

PLoS One. 2018 Nov 14;13(11):e0207434. doi: 10.1371/journal.pone.0207434. eCollection 2018.

19.

Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.

Alvarez-Márquez A, Aguilera I, Gentil MA, Caro JL, Bernal G, Fernández Alonso J, Acevedo MJ, Cabello V, Wichmann I, Gonzalez-Escribano MF, Núñez-Roldán A.

Transplantation. 2009 Jan 15;87(1):94-9. doi: 10.1097/TP.0b013e31818bd790.

PMID:
19136897
20.

The clinical and molecular significance of C4d staining patterns in renal allografts.

Hayde N, Bao Y, Pullman J, Ye B, Calder BR, Chung M, Schwartz D, Alansari A, de Boccardo G, Ling M, Akalin E.

Transplantation. 2013 Feb 27;95(4):580-8. doi: 10.1097/TP.0b013e318277b2e2.

PMID:
23274969

Supplemental Content

Support Center